President · Inhibrx Biosciences, Inc. · Inhibrx Biosciences, Inc. — Stock Option (right to buy)
Side
A
Value
—
Shares
50.0K
Price
—
Executed
Apr 24, 2026
Disclosed
Apr 27, 2026
Disclosure timeline3 days from execution to publication · legal deadline 2 business days
Apr 24 executedApr 27, 2026 disclosed
INBX · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Other disclosed activity · INBX
No records
No other disclosures for this security in the dataset.
Evidence
Verified data
Read directly from the primary public document; every field below is as reported by the filer.
Inhibrx Biosciences, Inc. — Stock Option (right to buy)
Ticker
INBX
Shares
50.0K
Price per share
$0
Execution date (reported)
Apr 24, 2026
Owned after transaction
50.0K shares
Days from execution to publication
3
What this establishes
Matly David filed this Form 4 reporting a grant or award of INBX on Apr 24, 2026. It became public on Apr 27, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
President
Matly Davidcik:0002062665
Issuer
Inhibrx Biosciences, Inc.cik:0002007919
Revision history · 0
No field has changed since this record was first ingested.